USPTO Discusses Duty of Disclosure

Patent and Trademark Office USPTO held virtual panel discussion on the duty of disclosure and duty of reasonable inquiry. While both duties apply regardless of technology area, the discussion supported USPTO initiatives pursuant to President Biden’s July 2021 Executive Order.

Related Keywords

United States ,American ,Kimberly Braslow ,Ronaldk Jaicks ,Roberta Clarke ,Office Of Patent Legal Administration ,Panel Discussion ,Drug Committee ,Trademark Office ,Acorn Mobility Services Ltd ,Hospira Inc ,Astrazeneca ,Belcher Pharms ,Office Of Enrollment ,Excavator Co ,Keystone Driller Co ,Bruno Independent Living Aids Inc ,President Biden ,Federal Register Notice ,Senators Leahy ,Patent Director ,Vice Chair ,Mary Till ,Matthew Sked ,Patent Legal Administration ,Bruno Independent Living Aids ,Acorn Mobility Services ,Federal Circuit ,Keystone Driller ,Precision Instruments ,Abbreviated New Drug Application ,New Drug Application ,Biologics License Application ,Legal ,Business ,Spto ,Patent Law ,Patent And Trademark Office ,Uty Of Disclosure ,Uty Of Reasonable Inquiry ,Competition Executive Order ,Biden Eo ,